{4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]phenyl}methanol

We are {4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]phenyl}methanol CAS:156755-37-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:{4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]phenyl}methanol
CAS.NO:156755-37-2
Synonyms:{4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]phenyl}methanol
(R)-(4-(benzyloxy)-3-(3-(diisopropylamino)-1-phenylpropyl)phenyl)methanol
O-Des(2-Methylpropan-1-one)-O-Benzyl-Fesoteridone
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 574.8±50.0 °C at 760 mmHg
Molecular Formula C29H37NO2
Molecular Weight 431.610
Flash Point 301.4±30.1 °C
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Fesoterodine Fumarate(CAS:286930-03-8).

{4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]phenyl}methanol


Related News: Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.2-bromopentanodioato de dietilo CAS:7209-00-9 From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.93249-44-6 The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.Diethyl ((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphonate CAS:116384-53-3 According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.”This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.

Related Products
Product Name
3,5-bis(chloromethyl)-2,2,6,6-tetramethylheptan-4-one View Details
2-Amino-4-chloro-6-methoxypyrimidine View Details
9,9-dimethyl-10-phenyl-9,10-dihydroacridine View Details
Bis(1,2,2,6,6-pentamethylpiperidin-4-yl) decanedioate manufacturer 1-METHYL-4-(PIPERIDIN-4-YL)-PIPERAZINE manufacturer 4-Chloro-4′-hydroxybenzophenone manufacturer N-(2,6-Dimethylphenyl)chloroacetamide manufacturer 4-(Methylsulfonyl)phenylacetic acid manufacturer